940 / 1498
Friedberg J W Hematology 2011;2011:498-505
300 DLBCL patients
50 ineligible for ASCT
100 relapses
200 cured
15 relapse
10 cured
90
Death from Lymphoma
25 don’t respond to
salvage
25 respond to
salvage
50 eligible for ASCT
Salvage Post-RCHOP